Jpmorgan Chase & CO Valneva Se Transaction History
Jpmorgan Chase & CO
- $1.14 Trillion
- Q2 2024
Shares
1 transactions
Others Institutions Holding VALN
# of Institutions
12Shares Held
653KCall Options Held
0Put Options Held
0-
General American Investors CO Inc354KShares$2.15 Million0.17% of portfolio
-
Wells Fargo & Company San Francisco, CA183KShares$1.11 Million0.0% of portfolio
-
Alpha Centric Advisors LLC San Juan, PR88.3KShares$535,6890.51% of portfolio
-
Ironwood Investment Management LLC Boston, MA25KShares$151,8830.1% of portfolio
-
Morgan Stanley New York, NY1.98KShares$12,0120.0% of portfolio
About Valneva SE
- Ticker VALN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 69,103,504
- Market Cap $419M
- Description
- Valneva SE, a specialty vaccine company, focuses on the development and commercialization of prophylactic vaccines for infectious diseases with unmet needs. Its commercial vaccines for travelers include IXIARO, an inactivated Vero cell culture-derived Japanese encephalitis vaccine indicated for active immunization against Japanese encephalitis; ...